Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$819,483
-$265,448 QoQ
Shares Held
350,207
-56.4% QoQ
Ownership
0.492%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ZNTL ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $819,483 | 350,207 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,084,931 | 803,654 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,125,820 | 1,407,829 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,273,272 | 1,097,651 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,739,390 | 1,093,958 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,190,956 | 1,713,188 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $5,930,564 | 1,611,567 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $7,978,450 | 1,950,722 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $16,349,562 | 1,037,409 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $9,233,663 | 609,483 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $10,945,133 | 545,620 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $14,186,100 | 502,875 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,665,738 | 271,264 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,687,861 | 133,459 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,109,548 | 97,394 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,715,260 | 345,739 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $8,205,765 | 177,845 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,533,900 | 30,144 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,214,111 | 48,231 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,643,241 | 68,482 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,302,663 | 53,069 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,241,783 | 100,920 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $247,593 | 7,574 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $486,202 | 10,125 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||